Skip to main navigation Skip to search Skip to main content

A systematic evaluation of the therapeutic potential of endogenous-ADAR editors in cancer prevention and treatment

  • Rona Merdler-Rabinowicz
  • , Ariel Dadush
  • , Sumeet Patiyal
  • , Padma Sheila Rajagopal
  • , Gulzar N. Daya
  • , Shay Ben-Aroya
  • , Alejandro A. Schäffer
  • , Eli Eisenberg
  • , Eytan Ruppin
  • , Erez Y. Levanon
  • National Institutes of Health
  • Bar-Ilan University
  • Tel Aviv University

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Adenosine deaminases acting on RNA (ADAR) enzymes constitute a natural cellular mechanism that induces A-to-I(G) editing, introducing genetic changes at the RNA level. Recently, interest in the endogenous-ADAR editor has emerged for correcting genetic mutations, consisting of a programmed oligonucleotide that attracts the native ADAR, thereby offering opportunities for medical therapy. Here, we systematically chart the scope of cancer mutations that endogenous-ADAR can correct. First, analyzing germline single nucleotide variants in cancer predisposition genes, we find that endogenous-ADAR can revert a fifth of them, reducing the risk of cancer development later in life. Second, examining somatic mutations across various cancer types, we find that it has the potential to correct at least one driver mutation in over a third of the samples, suggesting a promising future treatment strategy. We also highlight key driver mutations that are amenable to endogenous-ADAR, and are thus of special clinical interest. As using endogenous-ADAR entails delivering relatively small payloads, the prospects of delivering endogenous-ADAR to various cancers seem promising. We expect that the large scope of correctable mutations that are systematically charted here for the first time will pave the way for a new era of cancer treatment options.

Original languageEnglish
Article numberzcaf016
Number of pages10
JournalNAR Cancer
Volume7
Issue number2
DOIs
StatePublished - 1 Jun 2025

Bibliographical note

Publisher Copyright:
© The Author(s) 2025. Published by Oxford University Press on behalf of NAR Cancer.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A systematic evaluation of the therapeutic potential of endogenous-ADAR editors in cancer prevention and treatment'. Together they form a unique fingerprint.

Cite this